These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2437134)

  • 41. Identification of a polypeptide associated with the malignant phenotype in acute leukemia.
    Hanash SM; Strahler JR; Kuick R; Chu EH; Nichols D
    J Biol Chem; 1988 Sep; 263(26):12813-5. PubMed ID: 3417633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells.
    Wang H; Xie Z; Scott RE
    J Cell Biol; 1996 Nov; 135(4):1151-62. PubMed ID: 8922393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms.
    Wang H; Scott RE
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4649-53. PubMed ID: 8197114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of heterogeneous ribonuclear proteins.
    Minoo P; Sullivan W; Solomon LR; Martin TE; Toft DO; Scott RE
    J Cell Biol; 1989 Nov; 109(5):1937-46. PubMed ID: 2808514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
    Filipak M; Sparks RL; Tzen CY; Scott RE
    J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonterminally differentiated cells express decreased growth factor responsiveness.
    Hoerl BJ; Scott RE
    J Cell Physiol; 1989 Apr; 139(1):68-75. PubMed ID: 2708458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS; Wong W
    Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polypeptide changes associated with loss of proliferative potential during the terminal event in differentiation.
    Wier ML; Scott RE
    J Cell Biochem; 1987 Feb; 33(2):137-50. PubMed ID: 2437134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aproliferin: a modulator of proliferative potential.
    Wier ML; Scott RE
    Biofactors; 1988 Jul; 1(2):129-31. PubMed ID: 3076440
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.